Literature DB >> 20428217

Hematology: Treatment strategies for pediatric Hodgkin lymphoma.

John T Sandlund, Melissa M Hudson.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20428217     DOI： 10.1038/nrclinonc.2010.48

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.

Authors:  Lionel M L Chow; Paul C Nathan; David C Hodgson; Derek Jenkin; Sheila Weitzman; Ronald M Grant; David Manson; Adee Bross; John J Doyle; Cyril Danjoux; Mark L Greenberg
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

2.  Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma.

Authors:  Monika L Metzger; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

3.  Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

Authors:  Sarah S Donaldson; Michael P Link; Howard J Weinstein; Shesh N Rai; Sam Brain; Amy L Billett; Craig A Hurwitz; Matthew Krasin; Larry E Kun; Karen C Marcus; Nancy J Tarbell; Jeffrey A Young; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

4.  Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

Authors:  W Dörffel; H Lüders; U Rühl; M Albrecht; H Marciniak; R Parwaresch; R Pötter; G Schellong; E-W Schwarze; L Wickmann
Journal:  Klin Padiatr       Date:  2003 May-Jun       Impact factor: 1.349

5.  Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study group.

Authors:  Dennis A Eichenauer; Henning Bredenfeld; Heinz Haverkamp; Horst Müller; Jeremy Franklin; Michael Fuchs; Peter Borchmann; Hans-Konrad Müller-Hermelink; Hans T Eich; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

6.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Authors:  James B Nachman; Richard Sposto; Philip Herzog; Gerald S Gilchrist; Suzanne L Wolden; John Thomson; Marshall E Kadin; Paul Pattengale; P Charlton Davis; Raymond J Hutchinson; Keith White
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

7.  Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.

Authors:  Alison M Friedmann; Melissa M Hudson; Howard J Weinstein; Sarah S Donaldson; Larry Kun; Nancy J Tarbell; Michael P Link
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544

Review 8.  Treatment of pediatric hodgkin lymphoma.

Authors:  Michael R Olson; Sarah S Donaldson
Journal:  Curr Treat Options Oncol       Date:  2008-05-07

9.  A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

Authors:  Cindy L Schwartz; Louis S Constine; Doojduen Villaluna; Wendy B London; Robert E Hutchison; Richard Sposto; Steven E Lipshultz; Charles S Turner; Pedro A deAlarcon; Allen Chauvenet
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113

10.  Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

Authors:  Melissa M Hudson; Matthew Krasin; Michael P Link; Sarah S Donaldson; Catherine Billups; Thomas E Merchant; Larry Kun; Amy L Billet; Sue Kaste; Nancy J Tarbell; Scott Howard; Alison M Friedmann; Craig A Hurwitz; Jeffrey A Young; Karen C Marcus; Shesh Rai; Traci Cowan; Howard J Weinstein
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
  10 in total
  1 in total

1.  Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.

Authors:  Gaetano Corazzelli
Journal:  Transl Pediatr       Date:  2013-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.